Upfront Partners with athenahealth to Enhance Patient Engagement and Revenue Growth for Healthcare Providers Upfront Healthcare, a leading patient engagement technology company, has announced its partnership with athenahealth Inc. through…
eClinicalWorks’ AI Technology Enables York Primary Care to Save Over an Hour Daily on Fax Management eClinicalWorks®, the largest ambulatory cloud EHR provider, has announced that York Primary Care is…
ClearB Therapeutics Licenses Novel Saponin Adjuvant TQL-1055, to Present Hepatitis B Vaccine Data at AASLD 2024 ClearB Therapeutics, a company focused on developing therapeutic vaccines for a functional cure of…
Life Sciences Experts to Explore Global Collaboration, AI, and Clinical Trial Innovation at DIA Canada Annual Meeting The upcoming DIA Canada Annual Meeting, taking place on November 14-15 in Gatineau,…
CareSource and Nomi Health Partner to Improve Healthcare Access for Medicaid Members CareSource, a nonprofit health plan serving over 2 million members, has partnered with Nomi Health to launch a…
Komodo Health Unveils National Drug Projections for Real-Time Prescription Insights Komodo Health has launched its new product, National Drug Projections, offering a comprehensive view of prescription trends across the U.S.…
Clarametyx Biosciences Moves Forward with Phase 2a Study of CMTX-101 for Cystic Fibrosis Infections Clarametyx Biosciences, Inc. has successfully completed the Phase 1b portion of its clinical trial for CMTX-101,…
ModMed Empowers Ophthalmology Practices with Innovative Solutions at AAO 2024 ModMed® is excited to announce its participation in the American Academy of Ophthalmology (AAO) 2024 conference, taking place from October…
DNA Script Appoints Marc Montserrat as CEO, Thomas Ybert Transitions to Chief Scientific Officer DNA Script, a leader in enzymatic DNA synthesis, has appointed Marc Montserrat as its new Chief…
BenevolentAI benoemt Kenneth Mulvany tot uitvoerend voorzitter om AI-gestuurde geneesmiddelenontwikkeling te versnellen BenevolentAI, een toonaangevend bedrijf dat geavanceerde AI toepast voor de ontdekking en ontwikkeling van biofarmaceutische geneesmiddelen, heeft vandaag…
Kezar Life Sciences Updates on Clinical Trials for Zetomipzomib Kezar Life Sciences, Inc. (Nasdaq: KZR), a biotechnology company focused on developing innovative therapeutics for immune-mediated diseases, has provided important updates…
The “Peripheral Vascular Devices Market Report, Forecast by Device Type, Country and Company Analysis 2024-2032” has been added to ResearchAndMarkets.com. The global peripheral vascular devices market is projected to grow…